DFN 11

Drug Profile

DFN 11

Alternative Names: DFN-11; sumatriptan succinate; ZEMBRACESymTouch

Latest Information Update: 29 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Promius Pharma
  • Class Antimigraines
  • Mechanism of Action Serotonin 1B receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Migraine

Most Recent Events

  • 19 Dec 2016 Dr. Reddy's Laboratories terminates a pilot phase II trial in Migraine (medication overuse headaches) in USA (Parenteral) (NCT02583425)
  • 01 May 2016 Dr. Reddy's Laboratories completes a phase II trial for Migraine in USA (NCT02571049)
  • 19 Apr 2016 Launched for Migraine (In adults) in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top